DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
Everlywell offers one of the widest catalogs of mail-in home tests, from food sensitivity to thyroid and metabolic panels, processed by CLIA-certified labs.
Convenient, credible at-home labs, but skip the food sensitivity test
Everlywell makes routine lab testing easy: you self-collect a finger-prick, saliva, urine, or stool sample at home and mail it to a CLIA-certified lab, with a clinician reviewing the order and results in roughly 5 to 7 business days after the lab processes your sample. For standard biomarkers such as lipids, HbA1c, vitamin D, thyroid panels, and STIs, it is a reasonable convenience tool. The major caveat: its food-sensitivity (IgG) tests are not endorsed by major allergy societies and can lead to needless dietary restriction.
We may earn a commission if you buy through this link, at no extra cost to you. It never affects our score. How we make money
Independent third-party ratings, shown for context. Not affiliated with HealthVetted scoring.
Everlywell was founded in 2015 in Austin, Texas, by Julia Cheek, with the goal of making lab testing convenient and transparently priced for consumers rather than something that only happens through a doctor's office and an unpredictable insurance bill. The company became widely known during the pandemic: in May 2020 the FDA granted Everlywell an Emergency Use Authorization for the first standalone COVID-19 home-collection kit that was not tied to a single laboratory, allowing it to route samples to multiple authorized labs (FDA EUA, 2020).
Everlywell is the consumer brand of a larger parent company. In 2021 it acquired PWNHealth (a telehealth and physician-network company) and Home Access Health Corporation, and reorganized under the parent name Everly Health. That structure matters for understanding the product: the physician oversight, lab-network management, and the consumer testing brand are all part of the same corporate family. PWNHealth-derived clinician services power the "physician authorization" layer not only for Everlywell but, historically, for other DTC testing brands as well.
Crucially, Everlywell is a digital-health and logistics company wrapped around laboratory testing — it markets, ships, and presents results, and operates its own CLIA-certified, CAP-accredited lab (Everlywell Diagnostics) while also working with a network of certified partner labs depending on the assay. So when you buy an Everlywell kit, you are buying a coordinated package: kit + lab processing + an independent physician's order and review + a results dashboard.
The process is designed to remove the doctor's-office visit from routine testing:
The defining trade-off here is convenience versus sample quality. A finger-stick dried-blood-spot card is genuinely convenient and avoids a phlebotomy appointment, but it is a small, capillary-blood sample. For many screening biomarkers that is acceptable; for some analytes a professionally drawn venous sample is the clinical gold standard. This is the core distinction between a mail-in brand like Everlywell and a lab-network service such as Labcorp OnDemand or Quest, where most panels still require an in-person draw.
Everlywell offers a catalog of roughly two dozen at-home test kits (the exact count shifts as products are added or retired), plus some in-person options, spanning several categories:
The STI, thyroid, metabolic, vitamin D, and hs-CRP tests use standard, well-validated clinical assays with established reference ranges — these are mainstream diagnostics, and the value Everlywell adds is access and convenience, not a novel biomarker. The food sensitivity panel is the exception and is discussed in detail below, because it is both Everlywell's most famous product and its most scientifically criticized one.
Individual test prices are published per kit and span roughly $49 at the low end to several hundred dollars for large bundled or comprehensive panels. Single common tests (vitamin D, thyroid, an individual STI test) tend to sit in the lower-to-middle of that range, while broad multi-marker panels and comprehensive STI bundles are at the upper end.
Everlywell also sells a subscription, Everlywell+ (membership), which provides a monthly credit redeemable toward a test from the eligible catalog, a member discount on additional tests, and the ability to redeem a credit toward a virtual-care visit. Membership pricing has been advertised at different price points over time and by plan, so confirm the current monthly cost and the exact list of credit-eligible tests at checkout before subscribing. Note two practical caveats commonly attached to such plans: credits typically expire (often after about 12 months) and unused credits generally do not survive cancellation — so a membership only makes sense if you will actually test regularly.
On value, the honest framing is test-by-test, not brand-wide. For a standard panel, Everlywell is competitive but not always the cheapest: a comparable test at a lab-network service can be similar or lower in price, and the in-person draw those services use can be the more accurate sample. Two further cost realities: at-home tests are usually not covered by insurance (though many are FSA/HSA-eligible), and the sticker price is a screening cost, not a diagnosis — an abnormal result frequently leads to confirmatory testing through a physician, which is an additional downstream cost.
On the laboratory side, the foundation is solid. Everlywell's processing labs hold current CLIA certificates and CAP accreditation, maintain state licenses, and undergo routine inspections and proficiency testing — the same quality framework that governs physician-ordered labs (CMS/CLIA; CAP). Independent reporting and the broader DTC-testing literature have generally found that for standard biomarkers, properly collected direct-to-consumer samples correlate well with conventional venous testing.
The real accuracy questions with any at-home brand are pre-analytical — i.e., before the sample reaches the lab. Self-collection introduces variability: an insufficient finger-stick blood volume, a contaminated or mistimed sample, or shipping delays can degrade results or force a recollection. None of this is unique to Everlywell, but it is the honest counterweight to "lab-grade accuracy" marketing: the lab can be excellent and the result still be only as good as the sample you collected.
There is also an interpretation gap. Everlywell's dashboard and optional clinician review help, but a result without your full clinical context — symptoms, history, medications, and physical exam — is a data point, not a diagnosis. The most defensible use of these tests is screening and trend-tracking, with abnormal or worrying results taken to a physician for confirmation and management.
This is the most important caveat in any honest Everlywell review. The food sensitivity test measures IgG antibodies to a panel of foods. The scientific consensus among allergy and immunology specialists is that IgG to foods is not a valid marker of food intolerance or allergy. The European Academy of Allergy and Clinical Immunology (EAACI) issued a Task Force report concluding that testing for food-specific IgG4 is not recommended as a diagnostic tool (EAACI Task Force; PMID 18489614), and the American Academy of Allergy, Asthma & Immunology (AAAAI) has formally supported that position, stating it is neither appropriate nor reliable to use these antibody tests to diagnose food allergy (AAAAI/JACI). The Canadian Society of Allergy and Clinical Immunology (CSACI) reached the same conclusion in its own position statement (CSACI; PMC3443017).
The reasoning is biological: detecting food-specific IgG (and IgG4) generally reflects exposure and tolerance — a normal immune response to foods you eat regularly — not pathology. In other words, a "reactive" result often just means you eat that food. The practical harm is real: acting on an IgG panel can lead to unnecessary and sometimes broad dietary restriction, added cost, anxiety, and — particularly in children — risk of nutritional inadequacy.
To its credit, Everlywell is explicit that this kit does not diagnose food allergy or celiac disease, and frames the results as a starting point to guide an elimination-and-reintroduction process rather than a diagnosis. That framing is more responsible than some competitors' marketing. But it does not resolve the underlying problem: the biomarker the test measures is not endorsed by the relevant medical societies for this purpose. If your concern is a true food allergy, the validated tools are clinician-guided IgE testing and supervised oral food challenges; if you suspect celiac disease, the appropriate path is serologic celiac testing and, where indicated, endoscopy — not an IgG food panel.
Pros
Cons
Best for people who want low-friction screening or trend-tracking for standard biomarkers — vitamin D, thyroid, HbA1c/lipids, hs-CRP — and especially for private STI screening, where the discretion and at-home collection are a meaningful advantage and Everlywell can connect a positive result to treatment. It also suits people who are uninsured or want to bypass an office visit for a specific, well-validated test.
Skip it (or choose differently) if you are trying to diagnose a food allergy or intolerance — see an allergist for IgE testing and food challenges rather than buying an IgG panel. Be cautious if you have a known or suspected serious condition that needs a definitive, clinician-managed diagnosis; an at-home screen is the wrong tool for that. And if accuracy on a specific analyte is paramount, a venous draw through a lab-network service may be the better choice.
Against LetsGetChecked and myLAB Box, Everlywell competes on a similar at-home, mail-in model; the differences come down to specific test menus, per-test pricing, and how integrated the follow-up care is. Against Labcorp OnDemand and Quest, the trade-off is structural: those services run testing inside their own national lab networks and rely mostly on in-person venous draws — generally the more accurate sample for many analytes — whereas Everlywell's strength is the genuinely at-home, mail-in experience. For point-of-care convenience in STIs, a newer rapid option — the Visby Medical at-home PCR test for chlamydia, gonorrhea, and trichomoniasis, the first such test FDA-authorized for fully at-home over-the-counter use, and sold through Visby, Labcorp OnDemand, and Everlywell itself — returns results in about 30 minutes, but at a higher per-test price and a narrower scope.
The takeaway: there is no single "best" service. For private at-home STI screening and basic wellness markers, Everlywell is a strong, legitimate choice; for maximum analyte accuracy or the lowest price on a common panel, a lab-network service may win; and for food-allergy questions, none of these consumer kits substitutes for an allergist.
Everlywell is a legitimate, well-run at-home testing company with a real quality backbone — CLIA-certified, CAP-accredited lab processing, independent physician oversight, and a clear, user-friendly results experience. For private STI screening and for tracking standard wellness biomarkers without a doctor's visit, it delivers real, defensible value. The two honest caveats are that its convenient finger-stick collection is not always equivalent to a clinical venous draw, and — most importantly — its flagship food sensitivity (IgG) test relies on a biomarker that the leading allergy and immunology societies explicitly do not endorse for diagnosing food intolerance. Buy Everlywell test-by-test: choose its well-validated panels with confidence, skip the IgG food test, and treat every at-home result as a screening signal to confirm with a clinician rather than a final diagnosis.
Everlywell is a digital health company, not a lab or device maker. You order a kit online, self-collect a sample at home (dried blood spot from a finger prick, saliva, urine, swab, or stool depending on the test), and mail it back in a prepaid envelope. A clinician in an independent physician network reviews and approves the lab requisition; the sample is then analyzed at a CLIA-certified laboratory (some also CAP-accredited), and a clinician reviews eligible results before they post to your secure online portal, typically within about 5 to 7 business days of the lab processing the sample. Everlywell states its at-home collection methods are clinically validated against traditional in-clinic methods to help ensure accuracy.
Everlywell's value depends heavily on the specific test. The company states all at-home sample-collection methods are clinically validated against traditional in-clinic methods, and its dried-blood-spot, saliva, and urine approaches rely on collection methods with established laboratory use; samples are run in CLIA-certified, sometimes CAP-accredited labs. Its COVID-19 home collection kit received an FDA Emergency Use Authorization in May 2020, which Everlywell described as the first EUA of its kind issued to a digital health company rather than a single lab. By contrast, the food-sensitivity (IgG) test has no credible diagnostic support: the American Academy of Allergy, Asthma & Immunology states IgG testing is not recommended for diagnosing food allergy or intolerance, because IgG antibodies likely reflect normal exposure and tolerance to foods, not sensitivity. An allergist quoted by STAT News called IgG tests "completely useless" and warned they "do dramatic harm" by prompting unnecessary food elimination. Independent reviewers note standard biomarker results generally align with conventional lab testing, while finger-prick collection can introduce slightly more variance than a venous draw for some markers.
A realistic timeline of what Everlywell users typically experience. Individual results vary; this is educational, not medical advice.
You order a kit online (no doctor visit needed for most panels). It ships to your address and typically arrives within 3-5 business days. Available tests vary by state.
When the kit arrives, you register its unique ID to your account, then collect your sample (finger-prick dried blood spot, saliva, urine, or swab depending on the test). Collection usually takes only a few minutes; follow the timing instructions carefully (e.g. morning or fasting samples) for accurate results.
You drop the sealed sample in the mail using the included prepaid label. Transit to the CLIA-certified lab generally takes about 2-3 days. The clock on results does not start until the lab actually receives your sample.
After the lab receives your sample, most results are ready within about 5-7 business days. An independent physician reviews results before release; if a value is critically out of range, a clinician calls you. You get an email when results post to your dashboard. Order-to-results is commonly about 2-3 weeks total, and timing varies by test and shipping.
Results come with reference ranges and plain-language guidance. You can download a PDF, share it with your own doctor, or book an optional virtual care visit (a roughly 20-30 minute video call with a licensed clinician) to review findings and discuss next steps. An at-home test is a screening tool, not a diagnosis; abnormal results should be confirmed with a healthcare provider.
If you are tracking a marker over time or following up on a change, retesting at 1, 3, 6, or 12 months can show trends. Everlywell offers a membership for periodic testing (as often as monthly) plus year-round virtual care. How much results improve depends entirely on the underlying issue and the steps you and your provider take.
As a sample-collection service rather than a drug or treatment, Everlywell has no pharmacologic side effects. The main physical risk is from the finger-prick lancet: minor pain, a small bruise, or brief bleeding at the puncture site, and a low risk of infection if hygiene is poor. The more meaningful harms are interpretive: a false-positive or false-negative can cause unnecessary anxiety or false reassurance, and results are wellness information, not a diagnosis. The food-sensitivity (IgG) test carries a documented risk of prompting unwarranted food avoidance and overly restrictive diets, which allergists warn can be harmful. Always confirm and interpret results with a qualified clinician before changing diet, supplements, or medication.
Starts at $49 from Everlywell.
As of 2026, individual Everlywell tests generally range from about $49 to $299, with specialized add-on screenings priced much higher (the Galleri multi-cancer early-detection test has been listed around $949). An Everlywell+ membership has been offered at about $39/month or $449/year, including one free qualifying test monthly and a 20% discount on additional tests. Out of pocket, expect to pay the full sticker price: Everlywell generally does not bill insurance directly. However, many tests are clinician-authorized and can qualify for HSA/FSA payment or reimbursement using an itemized receipt; confirm with your benefits administrator first, since some plans deny wellness-only tests. Costs can rival or exceed an insured copay for the same test ordered through a doctor.
Prices current as of May 29, 2026 and exclude promo codes; cash-pay and channel pricing change frequently — confirm with the pharmacy or provider.
Everlywell earns its credibility through CLIA-certified labs (some also CAP-accredited) and clinician review, making it a convenient way to screen common markers privately. Treat results as wellness information to discuss with a clinician, not a diagnosis. Avoid the IgG food-sensitivity panel, which major allergy societies say lacks diagnostic validity, and remember finger-prick collection can be slightly less precise than a venous draw for some markers.
Yes, Everlywell is a legitimate service that processes samples in CLIA-certified (sometimes CAP-accredited) labs with clinician oversight, and it states its at-home collection methods are clinically validated against traditional in-clinic methods. Accuracy is generally strong for standard biomarkers, though finger-prick collection can be slightly less precise than a venous draw and results are not a diagnosis.
No, not as a medical test. It measures IgG antibodies, which major allergy societies including the AAAAI say likely reflect normal food exposure and tolerance, not sensitivity or intolerance. Allergists widely consider IgG testing unreliable for diagnosis and warn it can lead to unnecessary food avoidance and overly restrictive diets.
As of 2026, most individual Everlywell tests run roughly $49 to $299, with some specialized screenings priced much higher (the Galleri multi-cancer test has been listed around $949). An Everlywell+ membership has been offered around $39/month or $449/year, which includes one free qualifying test monthly and a 20% discount on additional tests.
Everlywell generally does not bill insurance, so you typically pay out of pocket. However, many tests are clinician-authorized and can qualify for HSA/FSA payment or reimbursement with an itemized receipt; confirm with your benefits administrator before buying, since some plans deny wellness-only tests.
Results for most tests are typically available within about 5 to 7 business days after the lab processes your sample, delivered through your secure online account. Mailing your sample early in the week helps avoid weekend shipping delays, which add to the total time.
You order a kit online, self-collect a sample at home (finger prick, saliva, urine, swab, or stool depending on the test), and mail it back in a prepaid envelope. An independent physician network reviews the order and eligible results, the sample is analyzed at a CLIA-certified lab, and results post to your online portal in roughly 5 to 7 business days after processing.
No. Everlywell results are wellness information, not a diagnosis, and the company recommends discussing them with a healthcare provider. It is useful for convenient screening, but symptoms, abnormal results, or existing conditions should be evaluated in person by a clinician.
Everlywell's STI tests are processed in CLIA-certified labs, and it also offers an in-person option using Quest Diagnostics collection. They are a reasonable private screening choice, and a provider contacts you about positive results, but any positive or symptomatic case should be confirmed and treated by a clinician.
Affiliate link — we may earn a commission at no extra cost to you, and it never changes our rankings or score. Disclosure
Same-category options, scored on the same six-axis rubric. Higher is better.